Jazz Pharmaceuticals gets EU nod for Ziihera

1 week ago 2

• Healthcare

koto_feja

• Jazz Pharmaceuticals (NASDAQ:JAZZ) said on Tuesday that the European Commission has granted conditional marketing authorization for its antibody therapy, Ziihera, as a monotherapy for the treatment of biliary tract cancer.
• The approval is specifically for adults with advanced biliary tract

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Jazz Pharmaceuticals gets EU nod for Ziihera